Form D · Pharmaceuticals
Nuovo Biologics, LLC
Davie, FL · CIK 0001509979
Offering snapshot reported Oct 18, 2012 · SEC filing
- Reported sold
- $425K Offering amount: $2M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Mar 12, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 18, 2012 | Initial | $425,000 | No comparison | 6 | SEC filing |
| Apr 18, 2011 | Amendment | $1,000,000 | $500,000vs Jan 12, 2011 | 9 | SEC filing |
| Jan 12, 2011 | Initial | $500,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-185731
Source: Form D, filed Oct 18, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gregory A Carney | Director, Executive |
| Donald Denkhaus | Director |
| Kent Miller | Director |
| Betty Rich | Director |
| Robert Savage | Director |
| Jay E. Yourist | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3901 Sw 47th Avenue Suite 404
Davie, FL, 33314
Davie, FL, 33314